| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.MRREV.2011.06.001 |
| P8608 | Fatcat ID | release_tobu767mebhqjdyqjwcdqpsjse |
| P932 | PMC publication ID | 4120774 |
| P698 | PubMed publication ID | 21703360 |
| P50 | author | Fazlul H. Sarkar | Q56648717 |
| P2093 | author name string | Bin Bao | |
| Zhiwei Wang | |||
| Dejuan Kong | |||
| Sanjeev Banerjee | |||
| Gilda G Hillman | |||
| P2860 | cites work | Selective growth regulatory and pro-apoptotic effects of DIM is mediated by AKT and NF-kappaB pathways in prostate cancer cells | Q40485942 |
| BRCA1 induces antioxidant gene expression and resistance to oxidative stress | Q40497271 | ||
| Parallel signal processing among mammalian MAPKs | Q40501929 | ||
| Physiological modeling of formulated and crystalline 3,3'-diindolylmethane pharmacokinetics following oral administration in mice | Q40509009 | ||
| Therapeutic activity of 3,3'-diindolylmethane on prostate cancer in an in vivo model | Q40526433 | ||
| Endoplasmic reticulum stress as a correlate of cytotoxicity in human tumor cells exposed to diindolylmethane in vitro | Q40532508 | ||
| Diindolylmethane alters gene expression in human keratinocytes in vitro | Q40691533 | ||
| Dietary indoles and isothiocyanates that are generated from cruciferous vegetables can both stimulate apoptosis and confer protection against DNA damage in human colon cell lines | Q40785886 | ||
| 2,3,7,8-Tetrachlorodibenzo-p-dioxin and diindolylmethanes differentially induce cytochrome P450 1A1, 1B1, and 19 in H295R human adrenocortical carcinoma cells. | Q40813823 | ||
| p21--negative regulator of the cell cycle | Q41226557 | ||
| Ah receptor binding properties of indole carbinols and induction of hepatic estradiol hydroxylation | Q42288805 | ||
| Aryl hydrocarbon receptor-mediated antiestrogenic and antitumorigenic activity of diindolylmethane | Q42539035 | ||
| The p38 MAPK pathway is critical for 5,5'-dibromodiindolylmethane-induced apoptosis to prevent oral squamous carcinoma cells | Q43233403 | ||
| 3,3'-Diindolylmethane attenuates experimental arthritis and osteoclastogenesis | Q43255618 | ||
| Methyl-substituted diindolylmethanes as inhibitors of estrogen-induced growth of T47D cells and mammary tumors in rats | Q43661614 | ||
| Bcl-2 family-mediated apoptotic effects of 3,3'-diindolylmethane (DIM) in human breast cancer cells | Q43738757 | ||
| Quantitative determination of 3,3'-diindolylmethane in urine of individuals receiving indole-3-carbinol | Q44048179 | ||
| Indole-3-carbinol and 3,3′-diindolylmethane induce apoptosis in human prostate cancer cells | Q44434784 | ||
| Acid reaction products of indole-3-carbinol and their effects on cytochrome P450 and phase II enzymes in rat and monkey hepatocytes. | Q44676971 | ||
| Pilot study: effect of 3,3'-diindolylmethane supplements on urinary hormone metabolites in postmenopausal women with a history of early-stage breast cancer | Q45204926 | ||
| 3,3'-Diindolylmethane inhibits angiogenesis and the growth of transplantable human breast carcinoma in athymic mice | Q45231913 | ||
| Indole-3-carbinol and 3,3'-diindolylmethane induce expression of NAG-1 in a p53-independent manner | Q45238294 | ||
| Phytochemical-induced changes in gene expression of carcinogen-metabolizing enzymes in cultured human primary hepatocytes | Q45239724 | ||
| Inhibition of growth factor-induced Ras signaling in vascular endothelial cells and angiogenesis by 3,3'-diindolylmethane | Q46122131 | ||
| A novel ring-substituted diindolylmethane,1,1-bis[3'-(5-methoxyindolyl)]-1-(p-t-butylphenyl) methane, inhibits extracellular signal-regulated kinase activation and induces apoptosis in acute myelogenous leukemia | Q46417590 | ||
| Mitochondria-dependent reactive oxygen species-mediated programmed cell death induced by 3,3'-diindolylmethane through inhibition of F0F1-ATP synthase in unicellular protozoan parasite Leishmania donovani. | Q46429094 | ||
| Inhibitory effects of a dietary phytochemical 3,3'-diindolylmethane on the phenobarbital-induced hepatic CYP mRNA expression and CYP-catalyzed reactions in female rats | Q46590712 | ||
| Indole-3-carbinol, but not its major digestive product 3,3'-diindolylmethane, induces reversible hepatocyte hypertrophy and cytochromes P450. | Q46618227 | ||
| 3,3'-diindolylmethane (DIM) and its derivatives induce apoptosis in pancreatic cancer cells through endoplasmic reticulum stress-dependent upregulation of DR5. | Q46839472 | ||
| Gene expression profiles of I3C- and DIM-treated PC3 human prostate cancer cells determined by cDNA microarray analysis | Q47996735 | ||
| Differences in the hepatic P450-dependent metabolism of estrogen and tamoxifen in response to treatment of rats with 3,3'-diindolylmethane and its parent compound indole-3-carbinol. | Q50959305 | ||
| Oral administration of 3,3'-diindolylmethane inhibits lung metastasis of 4T1 murine mammary carcinoma cells in BALB/c mice. | Q51606752 | ||
| Multiple, disparate roles for calcium signaling in apoptosis of human prostate and cervical cancer cells exposed to diindolylmethane. | Q52569386 | ||
| Cancer chemoprevention: principles and prospects. | Q53478356 | ||
| 3,3'-diindolylmethane and paclitaxel act synergistically to promote apoptosis in HER2/Neu human breast cancer cells. | Q53629560 | ||
| Adenomatous polyposis coli determines sensitivity to histone deacetylase inhibitor-induced apoptosis in colon cancer cells. | Q54455472 | ||
| 3,3'-diindolylmethane inhibits migration and invasion of human cancer cells through combined suppression of ERK and AKT pathways. | Q54626968 | ||
| Influence of indole carbinols and growth hormone on the metabolism of 4-androstenedione by rat liver microsomes | Q57665768 | ||
| Chemoprevention of cancer | Q69880729 | ||
| The anticarcinogen 3,3'-diindolylmethane is an inhibitor of cytochrome P-450 | Q70918066 | ||
| The role of c-Jun N-terminal kinase (JNK) in apoptosis induced by ultraviolet C and gamma radiation. Duration of JNK activation may determine cell death and proliferation | Q71833616 | ||
| 3,3'-Diindolylmethane induces CYP1A2 in cultured precision-cut human liver slices | Q77314605 | ||
| Indole-3-carbinol and diindolylmethane induce apoptosis of human cervical cancer cells and in murine HPV16-transgenic preneoplastic cervical epithelium | Q77340136 | ||
| Single-dose and multiple-dose administration of indole-3-carbinol to women: pharmacokinetics based on 3,3'-diindolylmethane | Q79428709 | ||
| Antiangiogenic effects of indole-3-carbinol and 3,3'-diindolylmethane are associated with their differential regulation of ERK1/2 and Akt in tube-forming HUVEC | Q84848256 | ||
| Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor | Q22009126 | ||
| Global cancer statistics | Q22241238 | ||
| Ligand-dependent interaction of the aryl hydrocarbon receptor with a novel immunophilin homolog in vivo | Q24314469 | ||
| The hsp90 chaperone complex regulates intracellular localization of the dioxin receptor | Q24550978 | ||
| MicroRNAs: target recognition and regulatory functions | Q24609584 | ||
| Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells | Q24651034 | ||
| 3,3'-Diindolylmethane induces a G(1) arrest in human prostate cancer cells irrespective of androgen receptor and p53 status | Q24652101 | ||
| Celecoxib analogues disrupt Akt signaling, which is commonly activated in primary breast tumours | Q24813725 | ||
| Epithelial-mesenchymal transitions in development and disease | Q27860630 | ||
| MicroRNA gene expression deregulation in human breast cancer | Q27860690 | ||
| Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B | Q27860731 | ||
| Role of the aromatic hydrocarbon receptor and [Ah] gene battery in the oxidative stress response, cell cycle control, and apoptosis | Q28140867 | ||
| Identification of Nrf2-regulated genes induced by the chemopreventive agent sulforaphane by oligonucleotide microarray | Q28202142 | ||
| Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals | Q28204565 | ||
| Current development of mTOR inhibitors as anticancer agents | Q28255366 | ||
| Association of the Ah receptor with the 90-kDa heat shock protein | Q28281332 | ||
| Estrogen induced metastatic modulators MMP-2 and MMP-9 are targets of 3,3'-diindolylmethane in thyroid cancer | Q28476759 | ||
| Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors | Q29547463 | ||
| The aryl hydrocarbon receptor complex | Q29618805 | ||
| microRNAs as oncogenes and tumor suppressors | Q29619907 | ||
| Evidence of insulin-stimulated phosphorylation and activation of the mammalian target of rapamycin mediated by a protein kinase B signaling pathway | Q30454351 | ||
| Induction of growth arrest and apoptosis in human breast cancer cells by 3,3-diindolylmethane is associated with induction and nuclear localization of p27kip | Q33292308 | ||
| Phase I clinical trial of histone deacetylase inhibitor: suberoylanilide hydroxamic acid administered intravenously. | Q33356908 | ||
| Induction of G1 and G2/M cell cycle arrests by the dietary compound 3,3'-diindolylmethane in HT-29 human colon cancer cells | Q33456210 | ||
| Chemopreventive agent 3,3'-diindolylmethane selectively induces proteasomal degradation of class I histone deacetylases | Q33597363 | ||
| Induction of cytochrome P4501A1. | Q33636653 | ||
| Selective activation of estrogen receptor-beta target genes by 3,3'-diindolylmethane | Q33772337 | ||
| Enhancement of docetaxel anticancer activity by a novel diindolylmethane compound in human non-small cell lung cancer | Q33837550 | ||
| Structural organization of the microsomal glutathione S-transferase gene (MGST1) on chromosome 12p13.1-13.2. Identification of the correct promoter region and demonstration of transcriptional regulation in response to oxidative stress | Q33899126 | ||
| 3,3'-Diindolylmethane (DIM) inhibits the growth and invasion of drug-resistant human cancer cells expressing EGFR mutants | Q33937876 | ||
| 3,3'-diindolylmethane enhances the efficacy of butyrate in colon cancer prevention through down-regulation of survivin | Q33980057 | ||
| The Pezcoller lecture: cancer cell cycles revisited | Q33987290 | ||
| Activation of checkpoint kinase 2 by 3,3'-diindolylmethane is required for causing G2/M cell cycle arrest in human ovarian cancer cells | Q34051616 | ||
| A phase I dose-escalation study of oral BR-DIM (BioResponse 3,3'- Diindolylmethane) in castrate-resistant, non-metastatic prostate cancer | Q34073969 | ||
| PKB/Akt mediates cell-cycle progression by phosphorylation of p27(Kip1) at threonine 157 and modulation of its cellular localization | Q34150579 | ||
| 3,3'-Diindolylmethane is a novel mitochondrial H(+)-ATP synthase inhibitor that can induce p21(Cip1/Waf1) expression by induction of oxidative stress in human breast cancer cells | Q34519972 | ||
| Modulation of aflatoxin B1-mediated genotoxicity in primary cultures of human hepatocytes by diindolylmethane, curcumin, and xanthohumols | Q34612062 | ||
| Therapy for recurrent respiratory papillomatosis. | Q34636170 | ||
| Concurrent inhibition of NF-kappaB, cyclooxygenase-2, and epidermal growth factor receptor leads to greater anti-tumor activity in pancreatic cancer | Q34979358 | ||
| Histone deacetylase inhibitors: from target to clinical trials | Q35011880 | ||
| Oral diindolylmethane (DIM): pilot evaluation of a nonsurgical treatment for cervical dysplasia. | Q35014562 | ||
| Activation of nuclear TR3 (NR4A1) by a diindolylmethane analog induces apoptosis and proapoptotic genes in pancreatic cancer cells and tumors | Q35020448 | ||
| Results from a dose-response study using 3,3'-diindolylmethane in the K14-HPV16 transgenic mouse model: cervical histology | Q35023935 | ||
| Whole body pharmacokinetic models | Q35186644 | ||
| Fas-mediated apoptosis in cholangiocarcinoma cells is enhanced by 3,3'-diindolylmethane through inhibition of AKT signaling and FLICE-like inhibitory protein | Q35607306 | ||
| Mitogen-activated protein kinases in apoptosis regulation | Q35743118 | ||
| Phase I study of an oral histone deacetylase inhibitor, suberoylanilide hydroxamic acid, in patients with advanced cancer | Q35758280 | ||
| Interplay of genes regulated by estrogen and diindolylmethane in breast cancer cell lines | Q35795746 | ||
| Sensitization of squamous cell carcinoma to cisplatin induced killing by natural agents | Q35954519 | ||
| Agonist and chemopreventative ligands induce differential transcriptional cofactor recruitment by aryl hydrocarbon receptor | Q36139135 | ||
| Cytochrome P450-mediated metabolism of estrogens and its regulation in human. | Q36236196 | ||
| Quantitative combination effects between sulforaphane and 3,3'-diindolylmethane on proliferation of human colon cancer cells in vitro. | Q40164660 | ||
| Activation of caspase-8 contributes to 3,3'-Diindolylmethane-induced apoptosis in colon cancer cells | Q40191546 | ||
| Down-regulation of androgen receptor by 3,3'-diindolylmethane contributes to inhibition of cell proliferation and induction of apoptosis in both hormone-sensitive LNCaP and insensitive C4-2B prostate cancer cells | Q40218951 | ||
| Gene expression profiling revealed survivin as a target of 3,3'-diindolylmethane-induced cell growth inhibition and apoptosis in breast cancer cells | Q40284922 | ||
| 3,3'-diindolylmethane is a novel topoisomerase IIalpha catalytic inhibitor that induces S-phase retardation and mitotic delay in human hepatoma HepG2 cells | Q40335255 | ||
| 3,3'-Diindolylmethane downregulates pro-survival pathway in hormone independent prostate cancer | Q40335810 | ||
| Down-regulation of c-FLIP contributes to the sensitization effect of 3,3'-diindolylmethane on TRAIL-induced apoptosis in cancer cells. | Q40336857 | ||
| 3,3'-Diindolylmethane, a cruciferous vegetable derived synthetic anti-proliferative compound in thyroid disease | Q40363109 | ||
| Inhibition of nuclear translocation of nuclear factor-{kappa}B contributes to 3,3'-diindolylmethane-induced apoptosis in breast cancer cells. | Q40467145 | ||
| The roles of BRCA1 and BRCA2 and associated proteins in the maintenance of genomic stability | Q36602569 | ||
| 3,3'-diindolylmethane reduces levels of HIF-1alpha and HIF-1 activity in hypoxic cultured human cancer cells | Q36663529 | ||
| Molecular basis for chemoprevention by sulforaphane: a comprehensive review. | Q36775326 | ||
| 3,3'-Diindolylmethane induces apoptosis in human cancer cells. | Q36831745 | ||
| 5,5'-Dibromo-bis(3'-indolyl)methane induces Kruppel-like factor 4 and p21 in colon cancer cells | Q36932062 | ||
| Anticarcinogenesis by dietary phytochemicals: cytoprotection by Nrf2 in normal cells and cytotoxicity by modulation of transcription factors NF-kappa B and AP-1 in abnormal cancer cells | Q36976619 | ||
| Single-dose pharmacokinetics and tolerability of absorption-enhanced 3,3'-diindolylmethane in healthy subjects | Q37014907 | ||
| Targeting of aryl hydrocarbon receptor-mediated activation of cyclooxygenase-2 expression by the indole-3-carbinol metabolite 3,3'-diindolylmethane in breast cancer cells | Q37105790 | ||
| Mammalian target of rapamycin repression by 3,3'-diindolylmethane inhibits invasion and angiogenesis in platelet-derived growth factor-D-overexpressing PC3 cells | Q37132900 | ||
| Down-regulation of uPA and uPAR by 3,3'-diindolylmethane contributes to the inhibition of cell growth and migration of breast cancer cells | Q37132905 | ||
| Chemoprevention of pancreatic cancer: characterization of Par-4 and its modulation by 3,3' diindolylmethane (DIM) | Q37154124 | ||
| Apoptosis-inducing effect of erlotinib is potentiated by 3,3'-diindolylmethane in vitro and in vivo using an orthotopic model of pancreatic cancer | Q37164282 | ||
| Cell cycle-dependent effects of 3,3'-diindolylmethane on proliferation and apoptosis of prostate cancer cells | Q37204538 | ||
| 3,3'-Diindolylmethane enhances taxotere-induced growth inhibition of breast cancer cells through downregulation of FoxM1. | Q37243057 | ||
| Inactivation of uPA and its receptor uPAR by 3,3'-diindolylmethane (DIM) leads to the inhibition of prostate cancer cell growth and migration | Q37335608 | ||
| RETRACTED: 3,3'-Diindolylmethane enhances chemosensitivity of multiple chemotherapeutic agents in pancreatic cancer | Q37345627 | ||
| The paradox of autophagy and its implication in cancer etiology and therapy | Q37378496 | ||
| Low concentrations of diindolylmethane, a metabolite of indole-3-carbinol, protect against oxidative stress in a BRCA1-dependent manner | Q37421782 | ||
| Diindolylmethane inhibits cervical dysplasia, alters estrogen metabolism, and enhances immune response in the K14-HPV16 transgenic mouse model | Q37440864 | ||
| MicroRNAs in cancer: small molecules with a huge impact | Q37474280 | ||
| MicroRNAs and future therapeutic applications in cancer. | Q37604233 | ||
| Targeting NR4A1 (TR3) in cancer cells and tumors | Q37825901 | ||
| DIM stimulates IFNgamma gene expression in human breast cancer cells via the specific activation of JNK and p38 pathways | Q38329951 | ||
| 3,3'-Diindolylmethane (DIM) induces a G(1) cell cycle arrest in human breast cancer cells that is accompanied by Sp1-mediated activation of p21(WAF1/CIP1) expression | Q38363872 | ||
| Induction of apoptosis in human prostate cancer cell line, PC3, by 3,3'-diindolylmethane through the mitochondrial pathway | Q38801802 | ||
| Effect of diindolylmethane on Ca(2+) movement and viability in HA59T human hepatoma cells | Q39575476 | ||
| 3,3'-Diindolylmethane inhibits prostate cancer development in the transgenic adenocarcinoma mouse prostate model | Q39608493 | ||
| 3,3′-Diindolylmethane negatively regulates Cdc25A and induces a G2/M arrest by modulation of microRNA 21 in human breast cancer cells | Q39665391 | ||
| Discovery and mechanistic characterization of a novel selective nuclear androgen receptor exporter for the treatment of prostate cancer | Q39752772 | ||
| Novel 3,3'-diindolylmethane derivatives: synthesis and cytotoxicity, structural characterization in solid state | Q39835913 | ||
| 3,3'-diindolylmethane induction of p75NTR-dependent cell death via the p38 mitogen-activated protein kinase pathway in prostate cancer cells | Q39846893 | ||
| 3,3'-Diindolylmethane enhances taxotere-induced apoptosis in hormone-refractory prostate cancer cells through survivin down-regulation | Q39852552 | ||
| Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells. | Q40048047 | ||
| 1,1-bis(3'-indolyl)-1-(p-methoxyphenyl)methane activates Nur77-independent proapoptotic responses in colon cancer cells | Q40063189 | ||
| Inactivation of NF-kappaB by 3,3'-diindolylmethane contributes to increased apoptosis induced by chemotherapeutic agent in breast cancer cells | Q40072453 | ||
| Regulation of FOXO3a/beta-catenin/GSK-3beta signaling by 3,3'-diindolylmethane contributes to inhibition of cell proliferation and induction of apoptosis in prostate cancer cells | Q40128741 | ||
| Inhibition of angiogenesis and invasion by 3,3'-diindolylmethane is mediated by the nuclear factor-kappaB downstream target genes MMP-9 and uPA that regulated bioavailability of vascular endothelial growth factor in prostate cancer | Q40149269 | ||
| P433 | issue | 1-2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 47-66 | |
| P577 | publication date | 2011-06-15 | |
| P1433 | published in | Mutation Research | Q6943732 |
| P1476 | title | Attenuation of multi-targeted proliferation-linked signaling by 3,3'-diindolylmethane (DIM): from bench to clinic | |
| P478 | volume | 728 |
| Q42360795 | 2,3,7,8-Tetrachlorodibenzo-p-dioxin has both pro-carcinogenic and anti-carcinogenic effects on neuroendocrine prostate carcinoma formation in TRAMP mice |
| Q35286427 | 3,3'-Diindolylmethane attenuates LPS-mediated acute liver failure by regulating miRNAs to target IRAK4 and suppress Toll-like receptor signalling |
| Q37254713 | 3,3'-diindolylmethane rapidly and selectively inhibits hepatocyte growth factor/c-Met signaling in breast cancer cells |
| Q36733539 | 3,39-Diindolylmethane Ameliorates Staphylococcal Enterotoxin B–Induced Acute Lung Injury through Alterations in the Expression of MicroRNA that Target Apoptosis and Cell-Cycle Arrest in Activated T Cells |
| Q58712023 | A new promising way of maintenance therapy in advanced ovarian cancer: a comparative clinical study |
| Q39214234 | Anticancer Natural Compounds as Epigenetic Modulators of Gene Expression |
| Q33766869 | Attenuation of Carcinogenesis and the Mechanism Underlying by the Influence of Indole-3-carbinol and Its Metabolite 3,3'-Diindolylmethane: A Therapeutic Marvel |
| Q88241612 | Autophagy inhibition improves the chemotherapeutic efficacy of cruciferous vegetable-derived diindolymethane in a murine prostate cancer xenograft model |
| Q35783888 | B-DIM impairs radiation-induced survival pathways independently of androgen receptor expression and augments radiation efficacy in prostate cancer |
| Q26742065 | Cellular and Molecular Mechanisms of 3,3'-Diindolylmethane in Gastrointestinal Cancer |
| Q36740689 | Chemoprevention of lung tumorigenesis by intranasally administered diindolylmethane in A/J mice |
| Q37330730 | Chemopreventive properties of 3,3'-diindolylmethane in breast cancer: evidence from experimental and human studies |
| Q33643070 | Comparative preclinical pharmacokinetics study of 3,3'-diindolylmethane formulations: is personalized treatment and targeted chemoprevention in the horizon? |
| Q34998460 | Contribution of transcription factor, SP1, to the promotion of HB-EGF expression in defense mechanism against the treatment of irinotecan in ovarian clear cell carcinoma. |
| Q34902352 | Dietary diindolylmethane suppresses inflammation-driven lung squamous cell carcinoma in mice |
| Q38818485 | Dietary phytochemicals as epigenetic modifiers in cancer: Promise and challenges |
| Q34142384 | Diindolylmethane suppresses ovarian cancer growth and potentiates the effect of cisplatin in tumor mouse model by targeting signal transducer and activator of transcription 3 (STAT3). |
| Q36217167 | Diindolylmethane-mediated Gli1 protein suppression induces anoikis in ovarian cancer cells in vitro and blocks tumor formation ability in vivo |
| Q38335029 | Effects of deranged metabolism on epigenetic changes in cancer |
| Q38725554 | Emerging importance of dietary phytochemicals in fight against cancer: Role in targeting cancer stem cells |
| Q34129835 | Epigenetic modifications by dietary phytochemicals: implications for personalized nutrition |
| Q36951938 | Epigenetic modifications of Nrf2 by 3,3'-diindolylmethane in vitro in TRAMP C1 cell line and in vivo TRAMP prostate tumors. |
| Q36759766 | First results of the double-blind randomized placebo-controlled multicenter clinical trial of DIM-based therapy designed as personalized approach to reverse prostatic intraepithelial neoplasia (PIN) |
| Q29543116 | Leucine signaling in the pathogenesis of type 2 diabetes and obesity |
| Q85711583 | Low-Toxicity Diindol-3-ylmethanes as Potent Antifouling Compounds |
| Q37326339 | Methanolic Extract Isolated from Root of Lycoris aurea Inhibits Cancer Cell Growth and Endothelial Cell Tube Formation In Vitro |
| Q34457265 | Molecular targets of naturopathy in cancer research: bridge to modern medicine |
| Q40305115 | Normal human immune cells are sensitive to telomerase inhibition by Brassica-derived 3,3-diindolylmethane,partly mediated via ERα/β-AP1 signaling |
| Q92808407 | Phytochemicals for the Prevention and Treatment of Gastric Cancer: Effects and Mechanisms |
| Q37469412 | Plant phytochemicals as epigenetic modulators: role in cancer chemoprevention |
| Q28385642 | Plants vs. cancer: a review on natural phytochemicals in preventing and treating cancers and their druggability |
| Q36439912 | Regulators of gene expression as biomarkers for prostate cancer |
| Q26745561 | Roles of Dietary Phytoestrogens on the Regulation of Epithelial-Mesenchymal Transition in Diverse Cancer Metastasis |
| Q34323757 | Safety and tolerability of DIM-based therapy designed as personalized approach to reverse prostatic intraepithelial neoplasia (PIN). |
| Q40420216 | Selective Aryl Hydrocarbon Receptor Modulator 3,3'-Diindolylmethane Impairs AhR and ARNT Signaling and Protects Mouse Neuronal Cells Against Hypoxia |
| Q37512204 | Targeted regulation of PI3K/Akt/mTOR/NF-κB signaling by indole compounds and their derivatives: mechanistic details and biological implications for cancer therapy |
| Q34690409 | The Role of Nutraceuticals in Pancreatic Cancer Prevention and Therapy: Targeting Cellular Signaling, MicroRNAs, and Epigenome |
| Q95852125 | The Role of Secondary Metabolites on Gynecologic Cancer Therapy: Some Pathways and Mechanisms |
| Q40767295 | The adverse outcome pathway for rodent liver tumor promotion by sustained activation of the aryl hydrocarbon receptor |
| Q38707912 | The bounty of nature for changing the cancer landscape |
| Q36402333 | The impact of cow's milk-mediated mTORC1-signaling in the initiation and progression of prostate cancer |
| Q37727325 | Ultra-flexible nanocarriers for enhanced topical delivery of a highly lipophilic antioxidative molecule for skin cancer chemoprevention |
Search more.